HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

hepaplastin

reagent used in liver function tests
Also Known As:
Hepaplastin
Networked: 26 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Tanaka, Kumiko: 1 article (04/2014)
2. Hirao, Akihiro: 1 article (04/2014)
3. Tanaka, Hironori: 1 article (04/2014)
4. Tanaka, Takahiro: 1 article (04/2014)
5. Kagawa, Miwako: 1 article (04/2014)
6. Taniguchi, Tatsuya: 1 article (04/2014)
7. Takayama, Tetsuji: 1 article (04/2014)
8. Tomonari, Testu: 1 article (04/2014)
9. Muguruma, Naoki: 1 article (04/2014)
10. Sato, Momoko: 1 article (04/2014)

Related Diseases

1. Liver Cirrhosis (Hepatic Cirrhosis)
2. Chronic Hepatitis (Chronic Active Hepatitis)
3. Intracranial Hemorrhages (Intracranial Hemorrhage)
4. Acidosis
5. Neoplasms (Cancer)
06/01/1991 - "The physical and laboratory findings on admission revealed splenomegaly, pancytopenia, hypocoagulopathy, liver hypofunction with a hepaplastin test of 55% and ICG Rmax of 0.6 mg/kg/min. Diagnostic imaging showed a hypoechoic mass 1.5 in diameter a low density area on the CT scan and a faint tumor stain on the AAG in the posterior inferior area of the liver. "
09/28/2005 - "We then analyzed the variables that could influence prognosis, including tumor size and number, the serum levels of AFP, the parameters of hepatic function (albumin, bilirubin, ALT, hepaplastin test, platelet number, and indocyanine green retention at 15 min (ICG-R15)), combined therapy with TACE, distant recurrence, and local recurrence. "
07/01/1999 - "Statistical analysis by chi 2 test showed that the favorable factors linked to 5-year survival were (a) diabetes mellitus (-), (b) albumin > 3.7 g/dl, (c) hepaplastin test > 61%, (d) indocyanine green retention test at 15 minutes < 16%, (e) curative resection (+), (f) alpha-fetoprotein < or = 32 ng/ml, (g) portal vein invasion (-), (h) intrahepatic metastasis (-), and (i) stage I and II. Statistical analysis by stepwise regression test showed that the favorable factors linked to 5-year survival were (a) intrahepatic metastasis (-), (b) diabetes mellitus, (c) indocyanine green retention test at 15 minutes < 16%, (d) curative resection (+) and (e) alpha-fetoprotein < or = 32 ng/ml. When patients diagnosed with HCC, patients selection for hepatectomy should be done, based on the total estimation, such as tumor invasiveness, liver functions, and diabetes mellitus."
08/01/2001 - "Univariate analysis revealed the presence of esophageal varices, the presence of hepatitis C virus infection, a platelet count of less than 10 x 10(4)/microliter, hepaplastin test, gamma-globulin, the histologically active hepatitis, tumor size, des-gamma-carboxy prothrombin > 0.1 AU/ml, positive portal vein invasion, and histologic grade as discriminating factors. "

Related Drugs and Biologics

1. Indocyanine Green (Cardio-Green)
2. monoethylglycinexylidide (L 86)
3. Bilirubin
4. acarboxyprothrombin (PIVKA)
5. Cholinesterases (Cholinesterase)
6. Vitamin K
7. Serum Albumin
8. Hemoglobins (Hemoglobin)
9. Fibrinogen (Factor I)
10. alpha-Fetoproteins (AFP)

Related Therapies and Procedures

1. Hepatectomy
2. Plasmapheresis